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VPS10P domain receptors emerge as central regula-
tors of intracellular protein sorting in neurons with
relevance for various brain pathologies. Here, we
identified a role for the family member SorCS2 in
protection of neurons from oxidative stress and epi-
lepsy-induced cell death. We show that SorCS2 acts
as sorting receptor that sustains cell surface expres-
sion of the neuronal amino acid transporter EAAT3 to
facilitate import of cysteine, required for synthesis of
the reactive oxygen species scavenger glutathione.
Lack of SorCS2 causes depletion of EAAT3 from
the plasmamembrane and impairs neuronal cysteine
uptake. As a consequence, SorCS2-deficient mice
exhibit oxidative brain damage that coincides with
enhanced neuronal cell death and increased mortal-
ity during epilepsy. Our findings highlight a protective
role for SorCS2 in neuronal stress response and pro-
vide a possible explanation for upregulation of this
receptor seen in surviving neurons of the human
epileptic brain.INTRODUCTION
Sorting of proteins to their correct target sites is fundamental for
maintaining proper cell functions. Intracellular protein sorting is
particularly challenging for neurons, composed of diverse sub-
cellular compartments in cell soma, dendrites, and axons. Not
surprisingly, aberrant neuronal protein sorting has therefore
been recognized as the underlying cause of many devastating
brain pathologies (Wang et al., 2013). In recent years, the charac-
terization of a class of intracellular sorting receptors, termed
VPS10P domain receptors, has shed light on the mechanisms2792 Cell Reports 26, 2792–2804, March 5, 2019 ª 2019 The Author
This is an open access article under the CC BY-NC-ND license (http://that govern protein sorting in neurons. VPS10P domain recep-
tors encompass a group of five structurally related type 1 trans-
membrane proteins expressed in neurons of the central and pe-
ripheral nervous systems. Gene family members are SORLA,
sortilin, as well as SorCS1, SorCS2, and SorCS3 (Willnow
et al., 2008). As a common feature, VPS10P domain receptors
act as sorting receptors that direct cargo proteins between
Golgi, cell surface, and endosomes. One of their ascribed func-
tions is the ability tomove signaling receptors to and from the cell
surface, providing control of neuronal signal reception. Exam-
ples of such activity include sorting of neurotrophin receptors
by sortilin (Vaegter et al., 2011) and SorCS1 and SorCS3 (Sub-
khangulova et al., 2018).
Recently, VPS10P domain receptors have received growing
attention because of their relevance for disorders of the human
brain. Thus, encoding genes have been associated with psychi-
atric diseases, including SORCS1with attention-deficit hyperac-
tivity disorder (Lionel et al., 2011) and SORCS2 with bipolar dis-
order (Baum et al., 2008; Ollila et al., 2009) and schizophrenia
(Christoforou et al., 2011). Although the molecular mechanisms
whereby VPS10P domain receptors affect brain diseases are still
not fully resolved, faulty protein transport has been identified as
one of the underlying reasons, as shown for SORLA as a sorting
receptor for the amyloid precursor protein in Alzheimer’s disease
(Andersen et al., 2005; Offe et al., 2006).
As well as by genetic association, VPS10P domain receptors
have also been implicated in brain pathologies by expression
studies identifying altered receptor levels in the diseased brains
of patients or animal models (Andersen et al., 2005; Reitz et al.,
2013; Saadipour et al., 2013). With relevance to this study,
Sorcs2 was identified as a gene strongly upregulated in an
experimental mouse model of temporal lobe epilepsy (TLE),
linking this receptor with neuropathologies associated with
brain seizures (VonDran et al., 2014). However, the underlying
mechanism of SorCS2 action, and whether it bears relevance
for epilepsy in humans, remained unclear. Combining unbiased(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
proteomic screens for SorCS2 targets with studies in receptor-
deficient mouse models and in patients with TLE, we now iden-
tified the function of this receptor in trafficking of the neuronal
glutamate and cysteine transporter EAAT3. SorCS2-facilitated
exposure of EAAT3 on the cell surface promotes uptake of
cysteine, the precursor to produce glutathione, a scavenger for
reactive oxygen species, and it protects neurons from oxidative
stress induced by seizures. Jointly, these findings uncovered the
significance of directed protein sorting for neuronal stress
response and as a neuroprotective pathway in epilepsy.
RESULTS
SorCS2 Is Upregulated in the Epileptic Human Brain and
Plays a Protective Role in an Experimental Model of TLE
Epilepsy is a complex chronic brain disorder characterized by
seizures, leading to circuit reorganization and neuronal cell
loss. Pathological features of the human disease can be recapit-
ulated in mouse models of epilepsy involving the administration
of chemoconvulsants, such as pilocarpine or pentylenetetrazol
(PTZ). With relevance to this study, SorCS2 emerged as one of
the proteins strongly upregulated in neurons of the hippocampus
3 days after status epilepticus induced by pilocarpine. Increased
receptor expression was particularly evident in the hilus and
cornus ammonis 2 (CA2) region (VonDran et al., 2014). To sub-
stantiate the relevance of this observation for human brain pa-
thology, we tested the expression pattern of SorCS2 in the
healthy and in the epileptic human hippocampuswith hippocam-
pal sclerosis (HS) (Figure 1A). In healthy tissue, we observed
robust SorCS2 expression in neurons of the hippocampus, in
agreement with its reported expression pattern in the murine
brain (Hermey et al., 2004) (Figure 1A, top left). In human TLE-
HS tissue, severe neuronal cell loss was visible in all hippocam-
pal regions, with the exception of CA2, which is particularly resis-
tant to epilepsy-driven degeneration (Figure 1A, top right) (Steve
et al., 2014). Strikingly, surviving neurons in the CA2 region of
TLE-HS tissue samples showed a substantial increase in SorCS2
levels, suggesting a role for SorCS2 in preventing neuron loss in
the course of epilepsy (Figure 1A, bottom).
To investigate SorCS2 functions in epilepsy, we turned to a
PTZ-induced kindling paradigm applied to mice either wild-
type (WT) or genetically deficient for Sorcs2 (referred to as
S2KO [SorCS2 knockout]) (Glerup et al., 2014). In this chronic
epilepsy model, mice were subjected to a sub-convulsive dose
of PTZ three times a week for 5 weeks and scored for the severity
of their seizures (0–5; 6 in case of death). Over time, mice repeat-
edly challenged with PTZ develop convulsions of increasing
severity (Becker et al., 1992). As seen for the epileptic human
brain (Figure 1A), we also observed substantially increased
levels of SorCS2 in the CA2 region of the hippocampus in PTZ-
kindledWTmice using immunohistochemistry (Figure 1B). Over-
all, S2KOmice presented a kindling phenotype comparable with
that of WT animals (Figures 1C and S1). Also, seizures resulting
from the first administration of PTZ, reflecting the acute response
to the stimulus, did not differ between SorCS2-deficient and
control animals (Figure 1C). However, we observed a striking dif-
ference in the mortality rate of the two genotype groups during
the course of the kindling experiment with the mortality ratebeing higher in S2KO compared with WT mice (Figure 1D). After
developing strong seizures (score 5), SorCS2-deficient mice
died within the next three sessions on average, whereas WT
mice survived for approximately six more sessions (Figure 1E).
This observation indicated that SorCS2-deficient mice were
prone to developing irreversible pathological changes during
kindling that eventually led to their death.
Loss of SorCS2 Aggravates Cell Death and Oxidative
Damage in a Murine Model of Epilepsy
Neuronal cell death caused by seizures has a critical impact on
the brain function (Dingledine et al., 2014). To test whether the
increased mortality of S2KO mice in the PTZ kindling paradigm
was accompanied by aggravated neuronal cell loss, we as-
sessed the number of dying cells in the hippocampi of WT and
S2KO mice by TUNEL staining at the end of the PTZ kindling
experiment. The number of TUNEL-positive cells was signifi-
cantly higher in CA2/3 regions of S2KO hippocampi compared
with WT tissue (Figures 2A and 2B). Because the kindling pheno-
type and the extent of seizures after the first PTZ dosewere com-
parable between the genotypes, we reasoned that the aggra-
vated cell death in S2KO hippocampi was not due to an overall
increase in responsiveness to PTZ. Possibly, repeated epileptic
seizures may lead to secondary changes in brain functions that
were more pronounced in the S2KO compared with the WT
brain. Because oxidative stress is a feature of epilepsy that likely
contributes to epilepsy-associated cell death (Shin et al., 2011),
we tested the levels of the oxidative stress marker 8-hydroxy-20-
deoxyguanosine (8OHdG) in mouse hippocampi after PTZ
kindling. 8OHdG is one of the predominant forms of free
radical-induced oxidative lesions in nuclear and mtDNA (Valava-
nidis et al., 2009). 8OHdG immunoreactivity was significantly
increased in S2KO hippocampi compared with WT tissues,
both in the dentate gyrus (DG) and the CA region (Figures 2C
and 2D). This observation suggested that brain damage induced
in S2KOmice by PTZ kindling might be related to increased sus-
ceptibility to oxidative stress.
In support of this concept, we documented an aggravated
response to oxidative stress in primary SorCS2-deficient neu-
rons, despite their normal activation by classical neuronal stim-
ulation. Thus, S2KO neurons responded normally to treatment
with the GABA-A receptor antagonist bicuculline, as reflected
by a similar extent of p-ERK induction in WT and S2KO neurons
(Figures 3A and 3B). In contrast, treatment with the oxidant H2O2
triggered an increase in levels of the oxidative stress marker
heme oxygenase-1 (HO-1) that was significantly more pro-
nounced in S2KO than in WT neurons (Figures 3C and 3D).
Oxidative stress was accompanied by a transient increase in
SorCS2 levels in WT neurons (Figures 3E and 3F), supporting
involvement of SorCS2 in stress response pathways.
Neuronal Surface Proteome Is Altered in S2KO Neurons
To elucidate SorCS2-dependent processes protecting neurons
from oxidative stress, we applied an unbiased proteomics
approach to identify molecular targets of SorCS2 in the neuronal
surface proteome. This approach was based on the established
role of VPS10P domain receptors in sorting proteins to and from
the neuronal cell surface and on the documented alterations inCell Reports 26, 2792–2804, March 5, 2019 2793
Figure 1. SorCS2 Is Upregulated in the Epileptic Human Brain and Plays a Protective Role in an Experimental Model of Temporal Lobe
Epilepsy
(A) SorCS2 immunostaining in the human control hippocampus and in the hippocampus of a patient with TLE and hippocampal sclerosis. CA and DG regions are
indicted by white dotted lines. Overviews (above) and higher magnifications of CA2 regions (below) are shown. Scale bars, overview, 1 mm; CA2 region, 100 mm.
See also Table S1.
(B) SorCS2 immunostaining (red) in the CA2 region of the hippocampus of control and PTZ-kindled wild-typemice. Sections are counterstained with DAPI. Scale
bar, 50 mm.
(C–E) Results of PTZ kindling experiments. Mice were injected with PTZ three times a week, as detailed in STAR Methods. n = 12 or 13 mice per genotype. See
also Figure S1.
(C) Seizure scores (from 0 [no seizure] to 5; 6 indicates death) in the function of time. Mean value ± SEM. ns, not significant. ***p < 0.001 (two-way repeated-
measures ANOVA).
(D) Survival curves in course of the PTZ kindling experiment. p = 0.0219 (Gehan-Breslow-Wilcoxon test).
(E) Latency (number of sessions) from score 5 to death for WT and S2KO mice. Mean value ± SEM. *p < 0.05 (unpaired t test).cargo exposure on the surface of cells lacking individual
VPS10P domain receptors (Mazella et al., 2010; Rohe et al.,
2013). We had applied this strategy successfully before to iden-
tify ligands for SorCS1 and SorCS3 (Subkhangulova et al.,
2018). Here, neuronal cell surface proteins in WT and S2KO pri-
mary neurons were purified and subjected to quantitative label-
free mass spectrometry analysis (Figure 4A). In this experiment,
we uncovered multiple proteins with altered abundance in the
neuronal cell surface fraction upon loss of SorCS2 (Figure 4B;
Tables S2 and S3). Proteins with decreased cell surface expo-2794 Cell Reports 26, 2792–2804, March 5, 2019sure in mutant neurons included SorCS2 (Figure 4B; Table
S2), substantiating our strategy for identifying alterations in the
neuronal cell surface proteome. Among the hits with altered
plasma membrane exposure, we identified cell surface recep-
tors, channels, and transporters, as well as proteins implicated
in intracellular trafficking processes (Table S2). These hits repre-
sent bona fide cell membrane proteins and membrane-associ-
ated proteins, as well as proteins possibly included in the cell
surface fraction as a result of their interaction with cell surface
proteins.
Figure 2. Loss of SorCS2 Aggravates Cell
Death and Oxidative Stress Response in Mu-
rine Epilepsy Model
(A) TUNEL staining (green) in the CA2/3 region of
the hippocampus of WT or S2KO mice after PTZ
kindling. GFAP (red) marks astrocytes. Sections are
counterstained with DAPI. Dashed lines indicate the
areas used for quantification. Scale bar, 100 mm.
(B) Quantification of TUNEL-positive cells in the
CA2/3 area. Mean ± SEM. n = 10 or 11 mice per
genotype. *p < 0.05 (unpaired t test).
(C) Immunostaining for oxidative stress marker
8OHdG (green) in hippocampi of WT and S2KO
mice after PTZ kindling. Sections are counter-
stained with DAPI. Scale bar, 250 mm.
(D) 8OHdG immunostaining intensity in the CA1–3
regions (CA) and dentate gyrus (DG) of WT and
S2KO mice after PTZ kindling. Mean ± SEM. n = 12
or 13 mice per genotype. *p < 0.05 (unpaired t test).Interestingly, two hits in our proteome screen, namely, JWA
and mGlur3, were implicated in oxidative stress response.
JWA is induced in cells in response to oxidative stress (Chen
et al., 2007) and is implicated in regulation of the synthesis of
the reactive oxygen species (ROS) scavenger glutathione (Wa-
tabe et al., 2008). Metabotropic glutamate receptors (mGlurs)
also play a role in protection from oxidative stress, as activation
of mGlur2 and mGlur3 increases synthesis of glutathione in dor-
sal root ganglion neurons (Berent-Spillson and Russell, 2007).
We confirmed increased levels of JWA in the S2KO mouse brain
(Figures 4C and 4D), as well as an increase in mGlur2/3 protein in
SorCS2-deficient primary neurons (Figures S2A and S2B) and
brain tissue (Figures S2D and S2E), substantiating the results
of our proteome screen. An increase in mGlur3 expression in
S2KO mice was already seen at the transcript level in both pri-
mary neurons and in brain (Figures S2C and S2F), while JWA
mRNA levels remained unchanged comparing the two geno-
types (Figures 4E and 4F). Aswe did not observe co-immunopre-
cipitation (coIP) of JWA or mGlur3 with SorCS2 (Figure S2G), we
reasoned that alterations in the levels of these two proteins likely
reflected secondary consequences of SorCS2 loss.
SorCS2 Colocalizes and Interacts with the Glutamate
and Cysteine Transporter EAAT3
So far, our data pointed to alterations in glutamatergic and
oxidative stress response systems in S2KO neurons. Both sys-
tems aremechanistically linked, as glutamate is not only a neuro-
transmitter but also a substrate for synthesis of glutathione, theCell Rmain cellular ROS scavenger. Synthesis
of glutathione requires two additional
amino acids, glycine and cysteine. Impor-
tantly, glutamate and cysteine are im-
ported into neurons by the same amino
acid transporter excitatory amino acid
transporter 3 (EAAT3; or excitatory amino
acid carrier 1 [EAAC1]) (Chen and Swan-
son, 2003). Of note, JWA modulates traf-ficking and function of EAAT3 (Lin et al., 2001; Ruggiero et al.,
2008), while activation of mGlur2/3 increased EAAT3 levels in gli-
oma cells (Aronica et al., 2003), providing a mechanistic link of
this amino acid transporter to hits in our proteome screen.
Next, we testedwhether EAAT3may represent a direct target of
SorCS2-dependent sorting in neurons. In support of this hypoth-
esis, expression patterns for SorCS2 and EAAT3 largely overlap-
ped in the mouse brain on the cellular level, particularly in the py-
ramidal neurons of the cortex and in neurons ofCA2 andDGof the
hippocampus (Figure 4G). EAAT3 is expressed both in excitatory
and in inhibitory GABAergic neurons (Conti et al., 1998). However,
we did not observe SorCS2 expression in GABAergic, GAD67-
positive neurons, neither in the mouse brain (Figure S3A) nor in
neuronal cultures (Figure S3B), suggesting that co-expression
of EAAT3 and SorCS2 occurs in excitatory neurons. In hippocam-
pal neurons and rat C6 glioma cells, immunosignals for both pro-
teins colocalized in intracellular vesicles, supporting a role for
SorCS2 in trafficking of EAAT3 (Figure 4H).
To substantiate EAAT3 as a target for SorCS2-mediated sort-
ing, we tested interaction of the two proteins by coIP. Direct
interaction was documented by coIP of EAAT3 with GFP-tagged
SorCS2 (SorCS2-GFP) in CHOcells (Figure 4I). No coIP of EAAT3
was seen with the control protein GFP-tagged b-galactosidase
(bG) (Figure 4I). We confirmed EAAT3 and SorCS2 interaction
by coIP of the endogenous proteins frommouse hippocampal ly-
sates of WTmice using anti-SorCS2 antisera (Figure 4J). No IP of
EAAT3 was seen using non-immune IgG or S2KO hippocampal
lysates (Figure 4J).eports 26, 2792–2804, March 5, 2019 2795
Figure 3. Loss of SorCS2 Aggravates Oxidative Stress Response in Primary Neurons
(A and B) Western blot analysis (A) of p-ERK levels in cell lysates after stimulation of primary WT and S2KO neurons with 20 mM bicuculline (BIC) for 30 min
and quantification thereof (B). Tubulin served as a loading control. Mean ± SEM. n = 6 or 7 independent neuronal preparations per genotype. ns, not significant.
***p < 0.001 (two-way ANOVA).
(C and D)Western blot analysis (C) of HO-1 levels in cell lysates after treatment of primaryWT and S2KO neurons with 200 mMH2O2 and quantification thereof (D).
Tubulin served as a loading control. Mean ± SEM. n = 9 independent neuronal preparations per genotype. ***p < 0.001 (two-way ANOVA with Sidak’s multiple-
comparisons test).
(E and F) Western blot analysis (E) of SorCS2 levels in cell lysates after treatment of primary WT neurons with 200 mMH2O2 and quantification thereof (F). Tubulin
serves as a loading control. Mean ± SEM. n = 9 independent neuronal preparations. ***p < 0.001 (one-way ANOVA).
In (A)–(F) mixed cortical-hippocampal cultures were used.Loss of SorCS2Leads toMissorting of EAAT3 inNeurons
To further substantiate EAAT3 as a target of sorting by SorCS2,
we studied levels and subcellular distribution of EAAT3 in pri-
mary neurons from WT and S2KO mice. Specifically, we
compared the total levels as well as the levels of EAAT3 in the
cell surface fraction using western blot analysis. During cell
lysate processing, EAAT3 tends to form aggregates that mani-
fest as higher molecular mass bands in addition to the monomer
(Gonza´lez et al., 2002; Danbolt et al., 2016). Consistent with this
notion, EAAT3 was seen as both monomeric and aggregated
forms in total cell lysate (Figure 5A, left) and in aggregated
form in the surface fraction (Figure 5A, right). To exclude any
bias from different affinities of the antisera for monomer versus
aggregates, we quantified signal intensities for both forms of
the protein separately as well as the total amount of EAAT3 pre-
sent in the samples.
Levels of EAAT3 in the total lysate and in the cell surface frac-
tion were significantly decreased in S2KO compared with WT
neurons (Figures 5A and 5B). This decrease was observed for
the total (aggregated) EAAT3 in the cell surface fraction, as
well as for monomeric and total EAAT3 in the neuronal lysate
(Figure 5B). We corroborated these findings in an alternative
cell model by transient knockdown of SorCS2 in the C6 glioma
cell line. Also for C6 cells, we observed monomeric and aggre-
gated EAAT3 in cell lysates. SorCS2 depletion in C6 cells led
to a significant decrease in the levels of aggregated and total
EAAT3 (Figures 5D and 5E).2796 Cell Reports 26, 2792–2804, March 5, 2019Finally, we substantiated the impact of SorCS2 deficiency on
the subcellular distribution of EAAT3 in the brain by performing
subcellular fractionation of murine brain lysates (Figure S4A).
No aggregation of EAAT3 occurred when processing tissue ly-
sates. Thus, in this and all subsequent studies usingmouse brain
tissue, only monomeric forms of EAAT3 were detected and
quantified. Using western blot analyses, we detected EAAT3 in
fractions P2 (crudemembranes including the plasmamembrane)
and P3 (intracellular vesicles) (Figure S4B). In refined fraction-
ations, EAAT3 localized to the extrasynaptic membranes (con-
taining the plasma membrane) (Figure S4C) and to the synapto-
somal fraction (Figure S4D), but not the post-synaptic density
(PSD1; Figure S4D). SorCS2 showed the same subcellular distri-
bution, with an obvious enrichment in the intracellular vesicle
fraction P3 (Figures S4B–S4D). In agreement with these findings,
immunostaining in primary hippocampal neurons located EAAT3
and SorCS2 to early endosomes and recycling endosomes,
characterized by Rab5 and Rab11, respectively (Figure S4E).
Comparing genotypes, levels of EAAT3 in the intracellular vesicle
fraction P3 were significantly lower in S2KO compared with WT
brain tissue (Figures 5F and 5G). This fraction contained Rab11-
positive recycling endosomes (Figure S4B) that are central to the
intracellular sorting and cell surface targeting of EAAT3 (Gonza´-
lez et al., 2007; Su et al., 2016). Loss of SorCS2 did not affect the
levels of Eaat3 transcript in primary neurons (Figure 5C) or brain
cortex or hippocampus (Figure 5H). Taken together, these find-
ings argued that alterations in levels and subcellular distribution
(legend on next page)
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of EAAT3 in SorCS2-deficient neurons were caused by post-
transcriptional perturbation, possibly by aberrant protein sorting.
SorCS2 Deficiency Targets EAAT3 to Late Endosomes
Loss of SorCS2 resulted in decreased cell surface exposure of
EAAT3 in cultured neurons (Figures 5A and 5B) and in a
decreased EAAT3 content in the intracellular vesicles fraction
P3 (Figures 5F and 5G). Using immunocytochemistry, we
explored the alternative fate of EAAT3molecules in SorCS2-defi-
cient primary neurons. We observed that the fraction of EAAT3
colocalizing with the late endosome marker Rab7 was signifi-
cantly larger in primary S2KO neurons compared with WT cells
(Figures 6A and 6B). To test whether missorting of EAAT3 to
late endosomes in SorCS2 mutant neurons may promote lyso-
somal catabolism of the transporter, we quantified the amount
of EAAT3 in the cell surface fraction of cells treated with lyso-
somal inhibitors. Blocking lysosomal proteolysis caused a signif-
icant increase in cell surface levels of EAAT3, indicating that
lysosomal catabolism contributes to the decrease in EAAT3
levels in S2KO neurons (Figures 6C and 6D).
SorCS2 Promotes Cysteine Import into Neurons
To evaluate the impact of missorting on EAAT3 activity, we
measured glutamate and cysteine uptake into primary neurons
from WT and SorCS2-deficient mice. [S35]-labeled cysteine or
[H3]-labeled glutamate were applied to cultured WT and S2KO
neurons, and their intracellular content was assayed over time.
Because EAAT3 is a sodium-dependent transporter, we per-
formed parallel assays in Na-containing (Na+) and Na-deprived
(Na) buffer to control for the contribution of Na-independent
transport to glutamate and cysteine uptake. No substantial
contribution of Na-independent mechanisms to glutamate
import into cultured neurons was noted (7% of total glutamate
uptake at 6 min; Figure 6E). For cysteine, Na-independent trans-
port accounted for 24% of total uptake at 6 min (Figure 6F).
Therefore, in subsequent experiments we corrected for its
contribution to cysteine import to exclusively quantify the Na-
dependent transport activity. ComparingWT andS2KOneurons,
glutamate uptake did not show any difference (Figure 6G), likely
explained by the fact that cultured neurons also express other
Na-dependent glutamate transporters (Chen and Swanson,
2003). By contrast, Na-dependent cysteine import was signifi-
cantly decreased in S2KO neurons (Figure 6H), documenting aFigure 4. Cell Surface Proteomics Reveals Targets for SorCS2-Depend
(A) Workflow of surface proteome analysis in primary neurons.
(B) Comparison of the surface proteomes of WT and S2KO primary neurons (
technical replicates per biological replicate). Threshold applied: log2ratio(S2KO/W
(C and D) JWA levels in brain lysates from WT (S2+) and S2KO (S2) mice as sh
N-cadherin served as loading control. Mean ± SEM. n = 6 mice per genotype. *p
(E and F) JWA mRNA levels in cortex (E) and hippocampus (hipp.) (F) of WT and S
per genotype.
(G) SorCS2 (red) and EAAT3 (green) immunostainings on mouse brain sections (
higher magnification of the overview pictures of cortex, dentate gyrus (DG), and
(H) SorCS2 (green) and EAAT3 (red) immunostainings in mouse hippocampal neur
with DAPI. Higher magnification insets are shown. Scale bars, 10 mm.
(I) Co-immunoprecipitation (coIP) of EAAT3 with SorCS2-GFP (S2), but not b-
replicated three times.
(J) coIP of EAAT3 with SorCS2 from mouse hippocampal lysates. IgG, non-spec
2798 Cell Reports 26, 2792–2804, March 5, 2019functional consequence of EAAT3 missorting in SorCS2-defi-
cient neurons. Impaired EAAT3-dependent cysteine import into
neurons results in reduced glutathione synthesis in this cell
type (Aoyama et al., 2006). In line with this concept, glutathione
levels in the CA2 region of SorCS2-deficient mice were signifi-
cantly reduced compared with WT animals (Figures 6I and 6J)
as shown by immunodetection of the glutathione-N-ethylmalei-
mide adducts (GSH:NEM) (Escartin et al., 2011).
Subcellular Distribution of EAAT3 Is Dynamically
Regulated during Epilepsy in a SorCS2-Dependent
Manner
SorCS2-dependent cell surface exposure of EAAT3 promotes
cysteine import and glutathione synthesis in neurons (Figures
6H–6J). To query whether this interaction bares relevance for
neuroprotection, we tested the functional interaction of both pro-
teins in response to oxidative stress in vitro and in vivo. In primary
neurons, H2O2 treatment increased colocalization of EAAT3 with
SorCS2 in intracellular vesicles (Figures 7A and 7B), supporting
the idea that EAAT3 might be dynamically sorted by SorCS2
upon oxidative stress. We corroborated the responsiveness of
EAAT3 to stress by documenting a dramatically increased immu-
nosignal for the transporter in the surviving neurons of the human
epileptic hippocampus, in particular in the CA2 region (Fig-
ure 7C), as previously shown for SorCS2 (Figure 1A). To test
whether dynamic sorting of EAAT3 also occurs in epilepsy and
depends on SorCS2, we assayed the subcellular distribution of
EAAT3 after PTZ kindling using subcellular fractionations of WT
and SorCS2-deficient brain tissues. In WT brains, we observed
a redistribution of EAAT3 from the intracellular vesicle fraction
P3 (including Rab11+ endosomes) to the extrasynaptic mem-
branes fraction (containing the plasma membrane) following
kindling compared with the control condition (Figures 7D and
7E). No such shift from P3 to the extrasynaptic membranes
fraction was seen in mouse brains lacking SorCS2 (Figures 7D
and 7E).
In conclusion, we identified a role for SorCS2 in dynamic intra-
cellular sorting of EAAT3 in response to oxidative stress, a
pathway that facilitates neuronal uptake of cysteine required
for production of glutathione. Loss of SorCS2 impairs EAAT3-
dependent uptake of cysteine and reduces glutathione levels,
which coincides with a compromised protection against epi-
lepsy-induced oxidative stress and neuronal cell death.ent Sorting
mixed cortical-hippocampal cultures). n = 3 biological replicates/group (two
T) = ± 0.5; false discovery rate (FDR) = 0.15. See also Tables S2 and S3.
own by western blot analysis (C) and densitometric quantification thereof (D).
< 0.05 (unpaired t test). See also Figure S2.
2KO mice as assessed by qRT-PCR (relative to actin). Mean ± SEM. n = 9 mice
single confocal z planes). Sections are counterstained with DAPI. Insets show
CA2. Scale bars, 50 mm. See also Figure S3.
ons (left) and C6 cells (right) (single confocal z planes). Cells are counterstained
galactosidase-GFP (bG), overexpressed in CHO cells. This experiment was
ific IgG; IP, immunoprecipitation. This experiment was replicated three times.
Figure 5. Loss of SorCS2 Leads to Missorting of EAAT3
(A and B) EAAT3 levels in total lysate and cell surface fractions of wild-type (WT) and S2KO (KO) neurons as shown by western blot analysis (A) and densitometric
quantification thereof (B). Tubulin and synaptophysin served as loading controls. Tubulin is not present in cell surface fraction. EAAT3monomers and aggregates
are present in total neuronal lysates, while in the cell surface fraction, only aggregates are detected. Intensities of immunosignals from the indicated monomeric
and aggregated forms of EAAT3 in the total lysates are shown separately, as well as combined (total). For the cell surface fraction, intensities of immunosignals
from aggregated EAAT3 were quantified. Mean ± SEM. n = 7 independent neuronal preparations per genotype. *p < 0.05 and **p < 0.01 (unpaired t test).
(C) EAAT3 mRNA levels in WT and S2KO primary neurons as assessed by qRT-PCR (relative to actin mRNA). Mean ± SEM. n = 5 or 6 independent neuronal
preparations per genotype.
(D and E) Levels of SorCS2 and EAAT3 in C6 cell lysates after SorCS2 knockdown (si-S2) as shown by western blot analysis (D) and densitometric quantification
thereof (E). Intensities of immunosignals from the indicatedmonomeric and aggregated forms of EAAT3 are shown separately, as well as combined (total). Tubulin
serves as loading control. Levels of aggregated and total EAAT3 are decreased after SorCS2 knockdown. Mean ± SEM. n = 9 independent transfection ex-
periments. *p < 0.05 and ***p < 0.001 (unpaired t test).
(F) Levels of SorCS2 and EAAT3 in total lysate (Tot.) and in P2 and P3 fractions fromWT and S2KOmouse brains. In tissue lysates and fractions, only monomeric
EAAT3 is present. Synaptophysin and actin served as loading controls. See also Figure S4.
(G) Quantification of EAAT3 (monomer) levels in P3 fractions of WT and S2KO mouse brains (normalized to synaptophysin) as exemplified in (F). Mean ± SEM.
n = 8 mice per genotype. *p < 0.05 (unpaired t test).
(H) EAAT3 mRNA levels in WT and S2KO cortices and hippocampi (hipp.) as assessed by qRT-PCR (relative to actin mRNA). Mean ± SEM. n = 9 mice per
genotype.
In (A)–(C) mixed cortical-hippocampal cultures were used.
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Figure 6. SorCS2 Deficiency Leads to Late Endosomal Sorting of
EAAT3 and Disrupts Cysteine Import into Neurons
(A) Immunostaining of EAAT3 and Rab7 in primaryWT and S2KO hippocampal
neurons (single confocal z planes). Cells are counterstained with DAPI (blue).
Bottom: colocalizing EAAT3 and Rab7-positive pixels are depicted in gray-
scale. Scale bar, 10 mm.
(B) Extent of colocalization of EAAT3 and Rab7 in WT and S2KO neurons. tM1,
fraction of EAAT3 overlapping with Rab7. Mean ± SEM. n = 10 neurons per
genotype. **p<0.01 (unpaired t test). Thisexperimentwas replicated three times.
(C) Western blot analysis of EAAT3 levels (two immunoreactive bands corre-
sponding to aggregated forms) in the cell surface fraction of S2KO neurons
under control conditions (lys. inh.) or after 2 h of treatment with lysosomal
inhibitors (lys. inh.+).
(D) Quantification of EAAT3 levels as exemplified in (C). Mean ± SEM. n = 5
independent neuronal preparations. **p < 0.01 (unpaired t test).
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The amino acid transporter EAAT3 is the main cysteine uptake
route in neurons acting as a rate-limiting step for synthesis of
the antioxidant glutathione. Although EAAT3 was initially
described as a glutamate transporter, more recent evidence ar-
gues that its major activity is cysteine import as EAAT3-deficient
mice show glutathione deficiency and age-related neurodegen-
eration (Aoyama et al., 2006). We now document a crucial func-
tion for the VPS10P domain receptor SorCS2 in controlling intra-
cellular trafficking and cell surface activity of EAAT3 and the
essential role of this sorting pathway for cysteine uptake and
neuronal stress response.
Intracellular trafficking of EAAT3 has been studied extensively,
identifying an exocytic and a recycling route taken by this trans-
porter. The exocytic route is used by EAAT3 during biosynthesis
and includes passage through endoplasmic reticulum and Golgi
to the plasma membrane (Yang and Kilberg, 2002). By contrast,
the recycling route is crucial for dynamic regulation of cell sur-
face levels of EAAT3 and involves clathrin-dependent endocy-
tosis followed by recycling through the Rab11+ compartment
back to the plasma membrane (Gonza´lez et al., 2007). Rab11+
recycling endosomes are central for maintaining EAAT3 activity,
as Rab11 dysfunction slows EAAT3 trafficking to the cell surface
and impairs cysteine uptake and glutathione biosynthesis (Li
et al., 2010).
We now uncovered amechanism of SorCS2-mediated sorting
of EAAT3 through Rab11+ recycling compartments that is essen-
tial for efficient targeting of EAAT3 to the neuronal cell surface
under normal and, importantly, under oxidative stress condi-
tions. Our data are most consistent with a model whereby
SorCS2 interacts with EAAT3 in Rab11+ vesicles to sustain a re-
cycling pool of EAAT3 that can dynamically mobilize transporter
molecules to the cell surface to facilitate uptake of cysteine un-
der stress conditions. In the absence of SorCS2, EAAT3 is aber-
rantly targeted to late endosomal compartments, depleting its
recycling pool (i.e., P3 fraction) and, ultimately, reducing the
amount of bioactive EAAT3 molecules at the neuronal cell sur-
face. As a caveat, the anti-EAAT3 antiserummay exhibit different
affinities for monomer versus aggregates of EAAT3 seen in ly-
sates from primary neurons (Figures 5A and 6C) and C6 cells
(Figure 5D). Thus, where applicable, we always quantified the
total levels of EAAT3 but also monomers and aggregates(E and F) [3H]-Glutamate (E) and [35S]-cysteine (F) uptake into primary WT
neurons in Na-containing (Na+) or Na-deprived (Na) buffer. Mean ± SEM.
(G) [3H]-Glutamate uptake into primary WT and S2KO neurons. Mean ± SEM.
n = 7 or 8 independent neuronal preparations per genotype. ***p < 0.001 (two-
way ANOVA).
(H) Na-dependent [35S]-cysteine uptake into primary WT and S2KO neurons.
Mean ± SEM. n = 9 independent neuronal preparations per genotype. ***p <
0.001 (two-way ANOVA with Sidak’s multiple-comparisons test).
(I) Immunostaining for glutathione:NEM adduct (GSH:NEM) (green) in CA2
regions of WT and S2KOmice. Sections were counterstained with DAPI (blue).
Scale bar, 50 mm.
(J) GSH:NEM signal intensities (normalized to DAPI) in the CA2 regions of WT
and S2KO mice as exemplified in (I). Mean ± SEM. n = 5 or 6 mice per geno-
type. *p < 0.05 (unpaired t test).
In (C)–(H) mixed cortical-hippocampal cultures were used.
Figure 7. Subcellular Distribution of EAAT3 Is Dynamically Regulated during Epilepsy in a SorCS2-Dependent Manner
(A) Immunostaining of EAAT3 (red) and SorCS2 (green) in cultured WT neurons (mixed cortical-hippocampal culture) non-treated (control) or treated with 200 mM
H2O2 for 30 min. Cells were counterstained with DAPI. Scale bar, 10 mm.
(B) Extent of colocalization of EAAT3 and SorCS2 in WT neurons under control conditions and after H2O2 treatment as exemplified in (A) (tM1, fraction of EAAT3
overlapping with SorCS2). Mean ± SEM. n = 10 neurons per condition. *p < 0.05 (unpaired t test). This experiment was replicated three times.
(C) Immunodetection of SorCS2 (red) and EAAT3 (blue) in CA1 and CA2 regions of the human control hippocampus and of the hippocampus of a patient with TLE
and hippocampal sclerosis. Higher magnification insets are shown. Scale bar, 100 mm.
(D) Distribution of EAAT3 in subcellular brain fractions from WT and S2KO mice under basal conditions (control) or after PTZ kindling (PTZ). ext, extrasynaptic
membranes; syn, synaptosomes; tot, total lysate. In tissue lysates and fractions, only monomeric EAAT3 is present. Synaptophysin and PSD95 were used as
fraction markers.
(E) Ratio of EAAT3 (monomer) in extrasynaptic membranes (ext) versus P3 fractions fromWT and S2KOmouse brains as exemplified in the western blot analysis
in (D). A shift of EAAT3 from P3 to extrasynaptic membranes is seen in WT but not S2KO brains upon PTZ kindling. Mean ± SEM. n = 6 samples per group. *p <
0.05 (two-way ANOVA) for interaction.separately to control for this possibility. In all experiments, both
total levels as awell as the level of one form of EAAT3were signif-
icantly reduced in samples lacking SorCS2. It remains unclear
why in cell lysates from primary neurons it is the monomeric
form but in C6 lysate the aggregated form of EAAT3 that shows
a significant difference comparing genotypes, but most likely a
different extent of EAAT3 aggregation in the two cell types ex-
plains this discrepancy. Importantly, this issue does not apply
to experiments performed in mouse brain tissues, in which
only monomeric EAAT3 is seen and significantly reduced in
SorCS2 mutant mice (Figure 5F). Likely, the decrease in EAAT3
levels is caused by wrongful targeting of EAAT3 molecules to
late endosomes, followed by lysosomal catabolism, as blockade
of lysosomal activity rescues EAAT3 levels in SorCS2-deficient
neurons. Although lysosomal degradation of EAAT3 is a physio-
logical mechanism to regulate its turnover (Yang and Kilberg,
2002), this catabolic fate seems overrepresented in neurons
lacking the sorting function of SorCS2.
In neurons, glutamate and cysteine transport capacities are
dynamically regulated by adjusting EAAT3 levels at the cell sur-
face (Fournier et al., 2004; Guillet et al., 2005). In line with a reg-
ulatory role for SorCS2 in this dynamic EAAT3 response, weobserved an increase in SorCS2 levels (Figures 3E and 3F) and
enhanced EAAT3-SorCS2 colocalization (Figures 7A and 7B) in
neurons upon oxidative stress. Also in vivo, in the epileptic brains
of humans and mouse models, we observed a dynamic
response of EAAT3 that coincided with increased levels of
SorCS2 (Figures 1A, 1B, and 7C–7E). Oxidative stress activates
protein kinase C (PKC) (Gopalakrishna and Jaken, 2000), a
potent regulator of plasmamembrane exposure of EAAT3 (Four-
nier et al., 2004). Whether PKC promotes cell surface sorting of
EAAT3 by increasing the activity of SorCS2 is not known, but
PKC activation was shown to induce phosphorylation of the
related VPS10P domain receptor SORLA (Lane et al., 2010).
Our data document that SorCS2 is crucial for protection
against oxidative damage and neuronal cell death in the PTZ
kindling model of epilepsy. Oxidative stress is a hallmark of epi-
lepsy-driven pathology and represents a major process underly-
ing the damaging effects of epileptic activity in the brain (Martinc
et al., 2014). Increased levels of oxidative stress have been
observed in virtually all epilepsy models (Shin et al., 2011) and
in epileptic humanbrains (Lo´pez et al., 2007). Increased oxidative
damage and cell death in SorCS2-deficient mice coincided with
acceleratedmortality. The causal link between oxidative damageCell Reports 26, 2792–2804, March 5, 2019 2801
and cell death with seizure-related mortality in the S2KO mouse
model remains to be corroborated. However, there is ample evi-
dence for a causative role of oxidative brain damage in mortality
as treatment with antioxidants reduces oxidative stress and im-
proves survival in epilepsy models (Pauletti et al., 2017).
Obviously, our present studies do not exclude that impairment
of other neuronal activities of SorCS2, such as sorting of NMDA
receptors (Ma et al., 2017) or control of neurotrophin signaling
(Anastasia et al., 2013; Deinhardt et al., 2011; Glerup et al.,
2016), may contribute to the increased sensitivity of mutant
mice to seizure-induced mortality. However, loss of the dynamic
response of EAAT3 to PTZ kindling (Figures 7D and 7E) strongly
argues for impaired cysteine uptake as a molecular cause of
enhanced oxidative stress and neuronal cell loss and associated
mortality in epileptic S2KO mice. This notion receives further
support from findings that levels and localization of EAAT3 are
altered in animal models of epilepsy and in the human epileptic
hippocampus (Crino et al., 2002).
Intriguingly, the functional interaction of SorCS2 with EAAT3 in
protection from oxidative stressmay not be restricted to epilepsy
but be relevant for multiple brain pathologies, explaining the as-
sociation of this receptor with psychiatric and neurodegenera-
tive diseases (Baum et al., 2008; Christoforou et al., 2011; Ollila
et al., 2009; Reitz et al., 2013). For example, altered brain levels
or localization of EAAT3 were also reported in patients suffering
from schizophrenia (Bauer et al., 2008) and Alzheimer’s disease
(Duerson et al., 2009). Also, in mouse models of Huntington’s
disease, both impaired SorCS2 function (Ma et al., 2017) and
aberrant EAAT3 localization leading to increased oxidative stress
(Li et al., 2010) were reported.STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENTS AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILS280B Human subjects
B Mouse model
B Neuronal cultures
B Cell lines
d METHOD DETAILS
B Plasmids, oligonucleotides, and cell transfections
B Neuronal treatments
B Purification of neuronal cell surface proteins
B Mass spectrometry analysis of neuronal cell surface
proteins
B PTZ kindling procedure
B Immunohistochemistry on human tissue
B Immunohistochemistry on mouse tissue and cultured
cells
B Tissue fractionation
B Immunoprecipitations
B Western blot
B Quantitative RT–PCR
B Cysteine and glutamate uptake assays2 Cell Reports 26, 2792–2804, March 5, 2019d QUANTIFICATION AND STATISTICAL ANALYSIS
B Image quantification
B Statistical analysis
SUPPLEMENTAL INFORMATION
Supplemental Information can be found with this article online at https://doi.
org/10.1016/j.celrep.2019.02.027.
ACKNOWLEDGMENTS
We are indebted to Jasper J. Anink, Andra Eisenmann, Tatjana Pasternack,
Kristin Kampf, and Maria Kahlow for expert technical assistance. This work
was supported by grants from the European Research Council (BeyOND
335692 to T.E.W.); the Helmholtz Association (AMPro to T.E.W.); the Berlin
Institute of Health (Collaborative Research Group 11220008, to T.E.W.); the
European Union’s Seventh Framework Programme (FP7/2007-2013, grant
agreement 602102, EPITARGET, to E.A. and K.L.); the European Union’s Ho-
rizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie
grant agreement 722053, EU-GliaPhD, to E.A.); and Polish Ministry of Science
and Education grant W19/7.PR/2014 (to K.L.).
AUTHOR CONTRIBUTIONS
Conceptualization, A.R.M., T.E.W., K.L., and E.A.; Methodology, A.R.M. and
G.D.; Investigations, A.R.M., A.A., K.S., K.N., E.A.V., O.P., G.D., R.F.-G.;
Writing of the Manuscript, A.R.M. and T.E.W.; Funding Acquisition, T.E.W.,
E.A., and K.L.; Resources, A.N.; Supervision, A.R.M., T.E.W., K.L., E.A., and
J.A.K.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: June 27, 2018
Revised: January 20, 2019
Accepted: February 7, 2019
Published: March 5, 2019
REFERENCES
Anastasia, A., Deinhardt, K., Chao, M.V., Will, N.E., Irmady, K., Lee, F.S.,
Hempstead, B.L., and Bracken, C. (2013). Val66Met polymorphism of BDNF
alters prodomain structure to induce neuronal growth cone retraction. Nat.
Commun. 4, 2490.
Andersen, O.M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke,
J., von Arnim, C.A.F., Breiderhoff, T., Jansen, P., Wu, X., et al. (2005). Neuronal
sorting protein-related receptor sorLA/LR11 regulates processing of the amy-
loid precursor protein. Proc. Natl. Acad. Sci. U S A 102, 13461–13466.
Aoyama, K., Suh, S.W., Hamby, A.M., Liu, J., Chan,W.Y., Chen, Y., and Swan-
son, R.A. (2006). Neuronal glutathione deficiency and age-dependent neuro-
degeneration in the EAAC1 deficient mouse. Nat. Neurosci. 9, 119–126.
Aronica, E., Gorter, J.A., Ijlst-Keizers, H., Rozemuller, A.J., Yankaya, B., Leen-
stra, S., and Troost, D. (2003). Expression and functional role of mGluR3 and
mGluR5 in human astrocytes and glioma cells: opposite regulation of gluta-
mate transporter proteins. Eur. J. Neurosci. 17, 2106–2118.
Bauer, D., Gupta, D., Harotunian, V., Meador-Woodruff, J.H., and McCullum-
smith, R.E. (2008). Abnormal expression of glutamate transporter and trans-
porter interacting molecules in prefrontal cortex in elderly patients with schizo-
phrenia. Schizophr. Res. 104, 108–120.
Baum, A.E., Akula, N., Cabanero, M., Cardona, I., Corona, W., Klemens, B.,
Schulze, T.G., Cichon, S., Rietschel, M., No¨then, M.M., et al. (2008). A
genome-wide association study implicates diacylglycerol kinase eta (DGKH)
and several other genes in the etiology of bipolar disorder. Mol. Psychiatry
13, 197–207.
Becker, A., Grecksch, G., R€uthrich, H.L., Pohle, W., Marx, B., and Matthies, H.
(1992). Kindling and its consequences on learning in rats. Behav. Neural Biol.
57, 37–43.
Berent-Spillson, A., and Russell, J.W. (2007). Metabotropic glutamate recep-
tor 3 protects neurons from glucose-induced oxidative injury by increasing
intracellular glutathione concentration. J. Neurochem. 101, 342–354.
Bl€umcke, I., Thom, M., Aronica, E., Armstrong, D.D., Bartolomei, F., Bernas-
coni, A., Bernasconi, N., Bien, C.G., Cendes, F., Coras, R., et al. (2013). Inter-
national consensus classification of hippocampal sclerosis in temporal lobe
epilepsy: a Task Force report from the ILAE Commission on Diagnostic
Methods. Epilepsia 54, 1315–1329.
Chen, Y., and Swanson, R.A. (2003). The glutamate transporters EAAT2 and
EAAT3 mediate cysteine uptake in cortical neuron cultures. J. Neurochem.
84, 1332–1339.
Chen, R., Qiu, W., Liu, Z., Cao, X., Zhu, T., Li, A., Wei, Q., and Zhou, J. (2007).
Identification of JWA as a novel functional gene responsive to environmental
oxidative stress induced by benzo[a]pyrene and hydrogen peroxide. Free
Radic. Biol. Med. 42, 1704–1714.
Christoforou, A., McGhee, K.A., Morris, S.W., Thomson, P.A., Anderson, S.,
McLean, A., Torrance, H.S., Le Hellard, S., Pickard, B.S., StClair, D., et al.
(2011). Convergence of linkage, association and GWAS findings for a candi-
date region for bipolar disorder and schizophrenia on chromosome 4p. Mol.
Psychiatry 16, 240–242.
Conti, F., DeBiasi, S., Minelli, A., Rothstein, J.D., and Melone, M. (1998).
EAAC1, a high-affinity glutamate tranporter, is localized to astrocytes and ga-
baergic neurons besides pyramidal cells in the rat cerebral cortex. Cereb. Cor-
tex 8, 108–116.
Crino, P.B., Jin, H., Shumate, M.D., Robinson, M.B., Coulter, D.A., and
Brooks-Kayal, A.R. (2002). Increased expression of the neuronal glutamate
transporter (EAAT3/EAAC1) in hippocampal and neocortical epilepsy. Epilep-
sia 43, 211–218.
Danbolt, N.C., Zhou, Y., Furness, D.N., and Holmseth, S. (2016). Strategies for
immunohistochemical protein localization using antibodies: What did we learn
from neurotransmitter transporters in glial cells and neurons. Glia 64, 2045–
2064.
Deinhardt, K., Kim, T., Spellman, D.S., Mains, R.E., Eipper, B.A., Neubert, T.A.,
Chao, M.V., and Hempstead, B.L. (2011). Neuronal growth cone retraction re-
lies on proneurotrophin receptor signaling through Rac. Sci. Signal. 4, ra82.
Dingledine, R., Varvel, N.H., and Dudek, F.E. (2014). When and how do sei-
zures kill neurons, and is cell death relevant to epileptogenesis? Adv. Exp.
Med. Biol. 813, 109–122.
Duerson, K., Woltjer, R.L., Mookherjee, P., Leverenz, J.B., Montine, T.J., Bird,
T.D., Pow, D.V., Rauen, T., and Cook, D.G. (2009). Detergent-insoluble
EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer’s
disease patients. Brain Pathol. 19, 267–278.
Escartin, C., Won, S.J., Malgorn, C., Auregan, G., Berman, A.E., Chen, P.-C.,
De´glon, N., Johnson, J.A., Suh, S.W., and Swanson, R.A. (2011). Nuclear fac-
tor erythroid 2-related factor 2 facilitates neuronal glutathione synthesis by up-
regulating neuronal excitatory amino acid transporter 3 expression.
J. Neurosci. 31, 7392–7401.
Fournier, K.M., Gonza´lez, M.I., and Robinson, M.B. (2004). Rapid trafficking of
the neuronal glutamate transporter, EAAC1: evidence for distinct trafficking
pathways differentially regulated by protein kinase C and platelet-derived
growth factor. J. Biol. Chem. 279, 34505–34513.
Glerup, S., Olsen, D., Vaegter, C.B., Gustafsen, C., Sjoegaard, S.S., Hermey,
G., Kjolby, M., Molgaard, S., Ulrichsen, M., Boggild, S., et al. (2014). SorCS2
regulates dopaminergic wiring and is processed into an apoptotic two-chain
receptor in peripheral glia. Neuron 82, 1074–1087.
Glerup, S., Bolcho, U., Mølgaard, S., Bøggild, S., Vaegter, C.B., Smith, A.H.,
Nieto-Gonzalez, J.L., Ovesen, P.L., Pedersen, L.F., Fjorback, A.N., et al.
(2016). SorCS2 is required for BDNF-dependent plasticity in the hippocampus.
Mol. Psychiatry 21, 1740–1751.Gonza´lez, M.I., Kazanietz, M.G., and Robinson, M.B. (2002). Regulation of the
neuronal glutamate transporter excitatory amino acid carrier-1 (EAAC1) by
different protein kinase C subtypes. Mol. Pharmacol. 62, 901–910.
Gonza´lez, M.I., Susarla, B.T.S., Fournier, K.M., Sheldon, A.L., and Robinson,
M.B. (2007). Constitutive endocytosis and recycling of the neuronal glutamate
transporter, excitatory amino acid carrier 1. J. Neurochem. 103, 1917–1931.
Gopalakrishna, R., and Jaken, S. (2000). Protein kinase C signaling and oxida-
tive stress. Free Radic. Biol. Med. 28, 1349–1361.
Guillet, B.A., Velly, L.J., Canolle, B., Masmejean, F.M., Nieoullon, A.L., and Pi-
sano, P. (2005). Differential regulation by protein kinases of activity and cell
surface expression of glutamate transporters in neuron-enriched cultures.
Neurochem. Int. 46, 337–346.
Hermey, G., Plath, N., H€ubner, C.A., Kuhl, D., Schaller, H.C., and Hermans-
Borgmeyer, I. (2004). The three sorCS genes are differentially expressed and
regulated by synaptic activity. J. Neurochem. 88, 1470–1476.
Lane, R.F., Gatson, J.W., Small, S.A., Ehrlich, M.E., and Gandy, S. (2010). Pro-
tein kinase C and rho activated coiled coil protein kinase 2 (ROCK2) modulate
Alzheimer’s APP metabolism and phosphorylation of the Vps10-domain pro-
tein, SorL1. Mol. Neurodegener. 5, 62.
Li, X., Valencia, A., Sapp, E., Masso, N., Alexander, J., Reeves, P., Kegel, K.B.,
Aronin, N., and Difiglia, M. (2010). Aberrant Rab11-dependent trafficking of the
neuronal glutamate transporter EAAC1 causes oxidative stress and cell death
in Huntington’s disease. J. Neurosci. 30, 4552–4561.
Lin, C.I., Orlov, I., Ruggiero, A.M., Dykes-Hoberg, M., Lee, A., Jackson, M.,
and Rothstein, J.D. (2001). Modulation of the neuronal glutamate transporter
EAAC1 by the interacting protein GTRAP3-18. Nature 410, 84–88.
Lionel, A.C., Crosbie, J., Barbosa, N., Goodale, T., Thiruvahindrapuram, B.,
Rickaby, J., Gazzellone, M., Carson, A.R., Howe, J.L., Wang, Z., et al.
(2011). Rare copy number variation discovery and cross-disorder compari-
sons identify risk genes for ADHD. Sci. Transl. Med. 3, 95ra75.
Lo´pez, J., Gonza´lez, M.E., Lorigados, L., Morales, L., Rivero´n, G., and Bauza´,
J.Y. (2007). Oxidative stress markers in surgically treated patients with refrac-
tory epilepsy. Clin. Biochem. 40, 292–298.
Ma, Q., Yang, J., Milner, T.A., Vonsattel, J.G., Palko, M.E., Tessarollo, L., and
Hempstead, B.L. (2017). SorCS2-mediated NR2A trafficking regulates motor
deficits in Huntington’s disease. JCI Insight 2, 88995.
Martinc, B., Grabnar, I., and Vovk, T. (2014). Antioxidants as a preventive treat-
ment for epileptic process: a review of the current status. Curr. Neuropharma-
col. 12, 527–550.
Mazella, J., Pe´trault, O., Lucas, G., Deval, E., Be´raud-Dufour, S., Gandin, C.,
El-Yacoubi, M., Widmann, C., Guyon, A., Chevet, E., et al. (2010). Spadin, a
sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept
in the antidepressant drug design. PLoS Biol. 8, e1000355.
Offe, K., Dodson, S.E., Shoemaker, J.T., Fritz, J.J., Gearing, M., Levey, A.I.,
and Lah, J.J. (2006). The lipoprotein receptor LR11 regulates amyloid beta pro-
duction and amyloid precursor protein traffic in endosomal compartments.
J. Neurosci. 26, 1596–1603.
Ollila, H.M., Soronen, P., Silander, K., Palo, O.M., Kieseppa¨, T., Kaunisto, M.A.,
Lo¨nnqvist, J., Peltonen, L., Partonen, T., and Paunio, T. (2009). Findings from
bipolar disorder genome-wide association studies replicate in a Finnish bipolar
family-cohort. Mol. Psychiatry 14, 351–353.
Pauletti, A., Terrone, G., Shekh-Ahmad, T., Salamone, A., Ravizza, T., Rizzi,
M., Pastore, A., Pascente, R., Liang, L.-P., Villa, B.R., et al. (2017). Targeting
oxidative stress improves disease outcomes in a rat model of acquired epi-
lepsy. Brain 140, 1885–1899.
Reitz, C., Tosto, G., Vardarajan, B., Rogaeva, E., Ghani, M., Rogers, R.S.,
Conrad, C., Haines, J.L., Pericak-Vance, M.A., Fallin, M.D., et al.; Alz-
heimer’s Disease Genetics Consortium (ADGC) (2013). Independent and
epistatic effects of variants in VPS10-d receptors on Alzheimer disease
risk and processing of the amyloid precursor protein (APP). Transl. Psychi-
atry 3, e256.Cell Reports 26, 2792–2804, March 5, 2019 2803
Rohe,M., Hartl, D., Fjorback, A.N., Klose, J., andWillnow, T.E. (2013). SORLA-
mediated trafficking of TrkB enhances the response of neurons to BDNF. PLoS
ONE 8, e72164.
Ruggiero, A.M., Liu, Y., Vidensky, S., Maier, S., Jung, E., Farhan, H., Robinson,
M.B., Sitte, H.H., and Rothstein, J.D. (2008). The endoplasmic reticulum exit of
glutamate transporter is regulated by the inducible mammalian Yip6b/
GTRAP3-18 protein. J. Biol. Chem. 283, 6175–6183.
Saadipour, K., Yang, M., Lim, Y., Georgiou, K., Sun, Y., Keating, D., Liu, J.,
Wang, Y.-R., Gai, W.-P., Zhong, J.-H., et al. (2013). Amyloid beta142 (Ab42)
up-regulates the expression of sortilin via the p75(NTR)/RhoA signaling
pathway. J. Neurochem. 127, 152–162.
Shin, E.-J., Jeong, J.H., Chung, Y.H., Kim,W.-K., Ko, K.-H., Bach, J.-H., Hong,
J.-S., Yoneda, Y., and Kim, H.-C. (2011). Role of oxidative stress in epileptic
seizures. Neurochem. Int. 59, 122–137.
Steve, T.A., Jirsch, J.D., and Gross, D.W. (2014). Quantification of subfield pa-
thology in hippocampal sclerosis: a systematic review and meta-analysis. Ep-
ilepsy Res. 108, 1279–1285.
Su, J.-F., Wei, J., Li, P.-S., Miao, H.-H., Ma, Y.-C., Qu, Y.-X., Xu, J., Qin,
J., Li, B.-L., Song, B.-L., et al. (2016). Numb directs the subcellular local-
ization of EAAT3 through binding the YxNxxF motif. J. Cell Sci. 129,
3104–3114.
Subkhangulova, A., Malik, A.R., Hermey, G., Popp, O., Dittmar, G., Rathjen, T.,
Poy, M.N., Stumpf, A., Beed, P.S., Schmitz, D., et al. (2018). SORCS1 and
SORCS3 control energy balance and orexigenic peptide production. EMBO
Rep. 19, e44810.2804 Cell Reports 26, 2792–2804, March 5, 2019Swiech, L., Blazejczyk, M., Urbanska, M., Pietruszka, P., Dortland, B.R., Malik,
A.R., Wulf, P.S., Hoogenraad, C.C., and Jaworski, J. (2011). CLIP-170 and IQ-
GAP1 cooperatively regulate dendrite morphology. J. Neurosci. 31, 4555–
4568.
Vaegter, C.B., Jansen, P., Fjorback, A.W., Glerup, S., Skeldal, S., Kjolby, M.,
Richner, M., Erdmann, B., Nyengaard, J.R., Tessarollo, L., et al. (2011). Sortilin
associates with Trk receptors to enhance anterograde transport and neurotro-
phin signaling. Nat. Neurosci. 14, 54–61.
Valavanidis, A., Vlachogianni, T., and Fiotakis, C. (2009). 8-hydroxy-20 -deox-
yguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogen-
esis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 27, 120–139.
VonDran, M.W., LaFrancois, J., Padow, V.A., Friedman, W.J., Scharfman,
H.E., Milner, T.A., and Hempstead, B.L. (2014). p75NTR, but not proNGF,
is upregulated following status epilepticus in mice. ASN Neuro. 6,
1759091414552185.
Wang, D., Chan, C.-C., Cherry, S., and Hiesinger, P.R. (2013). Membrane traf-
ficking in neuronal maintenance and degeneration. Cell. Mol. Life Sci. 70,
2919–2934.
Watabe, M., Aoyama, K., and Nakaki, T. (2008). A dominant role of GTRAP3-18
in neuronal glutathione synthesis. J. Neurosci. 28, 9404–9413.
Willnow, T.E., Petersen, C.M., and Nykjaer, A. (2008). VPS10P-domain recep-
tors - regulators of neuronal viability and function. Nat. Rev. Neurosci. 9,
899–909.
Yang, W., and Kilberg, M.S. (2002). Biosynthesis, intracellular targeting, and
degradation of the EAAC1 glutamate/aspartate transporter in C6 glioma cells.
J. Biol. Chem. 277, 38350–38357.
STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
anti-actin Abcam Cat# ab8227; RRID:AB_2305186
anti-EAAT3 Cell Signaling Cat# 14501
anti-EAAT3 Santa Cruz Biotechnology Cat# SC7761; RRID:AB_2302065
anti-p-ERK Cell Signaling Cat# 4370; RRID:AB_2315112
anti-GAD67 EMD Millipore Cat# MAB5406; RRID:AB_2278725
anti-GFP MBL International Cat# MBL598; RRID:AB_591816
anti-GFAP (Cy3-conj.) Sigma-Aldrich Cat# C9205; RRID:AB_476889
anti-GluA1 EMD Millipore Cat# MAB2263; RRID:AB_1977459
anti-GluA2 EMD Millipore Cat# MABN71; RRID:AB_10806492
anti-GSH:NEM EMD Millipore Cat# MAB3194; clone 8.1GSH;
RRID:AB_94744
anti-HO-1 Cell Signaling Cat# 70081
anti-JWA Trans Genic Cat# KR057; RRID:AB_1627138
anti-mGlur2/3 Novus Biologicals Cat# NB300-124; RRID:AB_2113758
anti-PSD95 Cell Signaling Cat# 3409; RRID:AB_1264242
anti-N-cadherin Cell Signaling Cat# 14215
anti-Rab5 Cell Signaling Cat# 2143; RRID:AB_823625
anti-Rab7 Cell Signaling Cat# 9367; RRID:AB_1904103
anti-Rab11 Cell Signaling Cat# 5589; RRID:AB_10693925
anti-SorCS2 R&D Systems Cat# AF4237; RRID:AB_2192264
anti-SorCS2 Lifespan Biosciences Cat# LS-C501334
anti-synaptophysin Synaptic Systems Cat# 101011; RRID:AB_887824
anti-tubulin EMD Millipore Cat# CP06
anti-8OHdG (FITC-conj.) Santa Cruz Biotechnology Cat# SC93871
Biological Samples
Human brain samples Department of Neuropathology
of the Academic Medical Center
(AMC) Amsterdam, the Netherlands
N/A
Chemicals, Peptides, and Recombinant Proteins
bicuculline Abcam Cat #ab120107
EZ-LinkSulfo-NHS-SS-Biotin Thermo Fisher Scientific Cat #21331
L-[35S]-cysteine PerkinElmer Cat# NEG022T001MC
L-[3,4-3H]-glutamic acid PerkinElmer Cat# NET490250UC
N-ethylmaleimide (NEM) Thermo Fisher Scientific Cat# 23030
pentylenetetrazol (PTZ) Sigma Cat# P6500-25G
Critical Commercial Assays
In Situ Cell Death Detection Kit, Fluorescein
(TUNEL)
Roche Cat# 11684795910
Experimental Models: Cell Lines
C6 rat glioma cell line Culture Collections (UK) Cat# 92090409
CHO cell line ATCC CCL-61
Experimental Models: Organisms/Strains
Sorcs2/ (S2KO) mice Glerup et al., 2014 N/A
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Oligonucleotides
Actb (actin) Thermo Fisher Scientific Cat# Mm02619580
Ar6ip5 (JWA) Thermo Fisher Scientific Cat# Mm00480826
Grm3 (mGlur3) Thermo Fisher Scientific Cat# Mm00725298
EAAT3 Thermo Fisher Scientific Cat# Mm00436590
ON-TARGET plus SMART pool Dharmacon Cat# L-085157-02-0005
ON-TARGET plus non-targeting Pool Dharmacon Cat# D-001810-10-05
Recombinant DNA
rat EAAT3 Gonza´lez et al., 2002 N/A
GFP-tagged b-Galactosidase Swiech et al., 2011 N/A
SorCS2-GFP Generated in-house N/A
Other
GFP-Trap_MA resin Chromotek Cat# gtma-20
Neutravidin agarose resin Thermo Fisher Scientific Cat# 29201CONTACT FOR REAGENTS AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact Thomas
Willnow (willnow@mdc-berlin.de).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human subjects
The cases included in this study were obtained from the archives of the Department of Neuropathology of the Academic Medical
Center (AMC) Amsterdam, the Netherlands. Hippocampal specimens from 6 patients undergoing surgery for drug-resistant TLE
were examined. The tissue was obtained and used in accordance with the Declaration of Helsinki and the AMC Research Code pro-
vided by the Medical Ethics Committee. All cases were reviewed independently by two neuropathologists and the classification of
hippocampal sclerosis was based on analysis of microscopic examination as described by the International League Against Epilepsy
(Bl€umcke et al., 2013). Hippocampal control tissues were obtained during autopsy of age-matched individuals without a history of
seizures or other neurological diseases (n = 6). Table S1 summarizes the clinical characteristics of patients and controls.
Mouse model
Micewith targeted disruption of Sorcs2 (S2KO) were described before (Glerup et al., 2014). S2KOmice on an inbred C57BL/6N back-
ground were used. For in vivo studies, mouse strain was kept by breeding of heterozygous animals and theWT and S2KO littermates
were used in experiments. Newbornmice for preparing neuronal cultures were obtained by breeding of homozygousWT (C57BL/6N)
or S2KO animals.
PTZ kindling experiments were performed using male mice at the age of 8-12 weeks. In all the other studies, brain tissue was
collected from the mice of both sexes at the age of 8-12 weeks.
All animal experimentation was performed in accordance with institutional guidelines following approval by the local authorities of
the State of Berlin (X9012/12, O0120/13) and by the First Ethical Committee in Warsaw (209/2016).
Neuronal cultures
Primary hippocampal or mixed cortical-hippocampal neuronal cultures were prepared from newborn S2KO and WT mice (postnatal
day 0-1) using enzymatic digestion with papain. For biochemical studies, cortical neurons were plated on plastic plates coated with
poly-D-lysine (Corning BIOCOAT) at a density of 64,000 cells/cm2 (biotinylation studies) or 83,000 cells/cm2 (neuronal stimulation).
For immunocytochemistry, hippocampal neurons were plated on glass coverslips coated with poly-D-lysine and laminin at a density
of 25,000 cells/cm2 and mixed cortical-hippocampal neurons were plated on glass coverslips coated with poly-D-lysine at a density
of 57,000 cells/cm2. Neurons were maintained in Neurobasal medium (Invitrogen) supplemented with B27, GlutaMAX, and penicillin/
streptomycin (Invitrogen). Neuronal cultures were used for experiments at day in vitro (DIV)10-13.e2 Cell Reports 26, 2792–2804.e1–e6, March 5, 2019
Cell lines
The C6 rat glioma cell line was purchased from Culture Collections (UK). The cells were maintained in DMEMmedium supplemented
with 5% FBS and penicillin/streptomycin (Invitrogen). CHO cells were obtained from ATCC and grown in DMEM medium supple-
mented with 10% FBS and penicillin/streptomycin (Invitrogen).
METHOD DETAILS
Plasmids, oligonucleotides, and cell transfections
Plasmids encoding rat EAAT3 and GFP-tagged b-Galactosidase were gifts fromMichael Robinson and Jacek Jaworski, respectively
(Gonza´lez et al., 2002; Swiech et al., 2011). The plasmid encoding murine SorCS2 tagged with GFP at the C terminus was generated
in-house. Lipofectamine TM 2000 was used for transfection of cells.
For transient knockdown of SorCS2 expression, Dharmacon siRNA (ON-TARGET plus SMART pool, L-085157-02-0005) or non-
targeting control siRNAwere used (ON-TARGET plus non-targeting Pool D-001810-10-05). Cells were transfected with siRNAs using
X-tremeGENE siRNA transfection reagent (Roche). Two days post transfection, cells were washed twice with TBS-Ca-Mg buffer
(20 mM Tris pH 7.6, 150 mM NaCl, 0.5 mM MgCl2, 1 mM CaCl2) and scraped in the lysis buffer containing 20 mM Tris pH 7.5,
150 mM NaCl, 2 mM EDTA, 0.5% Triton-X, 0.5% NP40, 2 mM MgCl2, 10% glycerol, and protease and phosphatase inhibitors.
The lysate was kept on ice for 30 minutes and centrifuged for 10 minutes to collect the supernatant. Protein content was measured
by BCA and samples were further prepared for western blot by adding Laemmli buffer and boiling.
Neuronal treatments
Neuronal cultures (mixed cortical-hippocampal) at DIV 10-12were used. For H2O2 treatment, H2O2was added to the conditioned cell
culture medium at a final concentration of 200 mM and cells were incubated for 0.5, 3, 6 or 16 hours at 37C. In case of bicuculline
treatment, bicuculline (Abcam) was added to the conditioned cell culture medium at a final concentration of 20 mM and cells were
incubated for 30 minutes at 37C. Control cells were left untreated. After the stimulation, cell culture plates were placed on ice
and washed 2 times with ice-cold TBS-Ca-Mg buffer. Next, neurons were scraped in lysis buffer containing 20 mM Tris pH 7.5,
150 mM NaCl, 2 mM EDTA, 0.5% Triton-X, 0.5% NP40, 2 mM MgCl2, 10% glycerol, and protease and phosphatase inhibitors.
The lysatewas centrifuged (16,100x g, 15min) to remove cell debris. The protein content wasmeasured byBCAmethod and samples
were prepared for western blotting. If the cells were used for immunostainings, theywere fixedwith 4%PFA/PBS after the stimulation.
To block lysosome function, the culture medium was supplemented with pepstatin (10 mM), leupeptin (100 mM), and chloroquine
(50 mM), and the cells were incubated for 2 hours at 37C prior to cell surface biotinylation.
Purification of neuronal cell surface proteins
Mixed cortical-hippocampal neuronal cultures prepared from newbornWT or S2KOmice were plated on poly-D-lysine-coated plates
and cell surface biotinylation was performed at DIV10-12. To do so, cells were cooled down on ice for 15min andwashed 3 timeswith
PBS-Mg-Ca (PBS supplemented with 0.5 mM MgCl2 and 1 mM CaCl2). Next, cells were incubated on ice with EZ-Link
Sulfo-NHS-SS-Biotin solution (Thermo Fisher Scientific; 0.5 mg/ml in PBS) for 25 min, washed 3 times with quenching buffer
(40 mM glycine, 0.4% BSA in TBS-Ca-Mg) and 2 times with TBS-Ca-Mg. Cells were scraped in lysis buffer (50 mM Tris pH 7.5,
1 mM EDTA, 2 mM EGTA, 150 mM NaCl, 1% NP40, 0.5% DOC, 0.1% SDS, protease and phosphatase inhibitors) and the lysates
were rotated for 1.5 hours at 4C. After centrifugation (15 min, 14,000x g), the supernatants were used for pull down of biotinylated
proteins with NeutrAvidin slurry (Thermo Fisher Scientific). Equal amounts of proteins were loaded on the slurry. After washing 3 times
with lysis buffer, the beads were snap-frozen and stored at 80C until mass spectrometry analysis or boiled in Laemmli buffer to
release captured proteins for western blot analysis.
Mass spectrometry analysis of neuronal cell surface proteins
Mass spectrometry analysis was performed as described (Subkhangulova et al., 2018). Samples containing biotinylated cell surface
proteins were run on a stacking SDS-PAGE collecting all proteins in a single band. After Coomassie staining, the gel pieces were
minced and digested with trypsin using a PAL robot (Axel Semrau/CTC Analytics). Peptides were extracted with extraction buffer
(80% acetonitrile, 0.1% [v/v] formic acid) and dried in a speed-vac, followed by purification on C18 stage-tips. The eluted peptides
were dried in a speed-vac and resuspended in 3% acetonitrile, 0.1% (v/v) formic acid.
The samples were measured by LC-MS/MS on a Q-Exactive Plus mass spectrometer (Thermo) connected to a Proxeon easy-nLC
system (Thermo). The peptides were separated on an in-house prepared nano-LC column (0.074 mm3 250 mm, 3 mmReprosil C18,
Dr Maisch GmbH) using a flow rate of 0.25 ml/min. MS acquisition was performed at a resolution of 70,000 in the scan range from 300
to 1,700m/z. MS2 scans were carried out at a resolution of 15,500with the isolation window of 2.0m/z. Dynamic exclusion was set to
30 s, and the normalized collision energy was specified to 26.
For analysis, theMaxQuant software package version 1.5.2.8 was used. An FDR of 0.01 was applied for peptides and proteins, and
the Andromeda search was performed using a mouse Uniprot database (August 2014). MS intensities were normalized by the
MaxLFQ algorithm implemented in MaxQuant. MaxLFQ-normalized intensities among the replicates of the two groups to be related
were used for statistical comparison. Decoy hits, contaminants and proteins that have only been identified by a site have been filteredCell Reports 26, 2792–2804.e1–e6, March 5, 2019 e3
out from the resulting protein groups table. Proteins were further filtered for at least 2 valid values in one group beforeWelch t test was
applied. Resulting p-values were adjusted using the Benjamini-Hochberg procedure with an FDR-cutoff of 0.15. Further cutoff was
applied on the log2ratio(S2KO/WT) level with values greater than 0.5 or lower than 0.5 considered as enriched. For data visualiza-
tion, the –log10(p-value) was plotted against the log2ratio(S2KO/WT) using R (http://www.r-project.org). For better visualization, for
proteins detected in either S2KO or WT samples only, the log2ratio(S2KO/WT) was set to 10 or 10, respectively.
PTZ kindling procedure
For up to 5weeks,micewere intraperitoneally injectedwith subconvulsive doses (40mg/kg bodyweight) of pentylenetetrazol (PTZ) in
saline between 9:00 and 11:00 a.m. three times a week as described (Becker et al., 1992). After each injection, the convulsive
behavior was video recorded for 30 min and the resultant seizures were scored as follows: stage 0, no response; stage 1, ear and
facial twitching; stage 2, convulsive waves axially through the body; stage 3, myoclonic jerks and rearing; stage 4, turning over
onto the lateral position; stage 5, turning over into the back and generalized tonic-clonic seizures and 6, for animals that died during
the seizure. Latency from PTZ injection to seizure and the number of seizures in each session were also scored. The animals were
considered to be kindled after having had at least three consecutive sessions when they reached stage 5 seizures. After completion
of the experiment (15 sessions) or when animals died during the seizure, their brains were snap frozen on dry ice.
Immunohistochemistry on human tissue
Human brain tissue was fixed in 10% buffered formalin and embedded in paraffin. Paraffin-embedded tissue was sectioned at 5 mm,
mounted on pre-coated glass slides (Star Frost, Waldemar Knittel) and processed for immunohistochemical staining. Sections were
deparaffinated in xylene, rinsed in ethanol (100%, 95%, 70%), and incubated for 20 minutes in 0.3% hydrogen peroxide diluted in
methanol. Antigen retrieval was performed using a pressure cooker in 10 mM sodium citrate, pH 6.0 at 120C for 10 minutes. Slides
were washed with phosphate-buffered saline (PBS; 0.1 M, pH 7.4) and incubated overnight with primary antibody (rabbit anti-
SorCS2, Lifespan Biosciences, LS-C501334, 1:450) in Normal Antibody Diluent (Immunologic, Duiven, the Netherlands) at 4C. After
washing in PBS, sections were stained with a polymer-based peroxidase immunohistochemistry detection kit (Brightvision plus kit,
ImmunoLogic) according to the manufacturer’s instructions. Staining was performed using Bright DAB substrate solution (Immuno-
Logic, Duiven, the Netherlands). Sections were dehydrated in alcohol and xylene, and coverslipped.
For double-labeling of SorCS2 with EAAT3, rabbit anti-SorCS2 (Lifespan Biosciences, LS-C501334, 1:450) and rabbit anti-EAAT3
(Cell Signaling, #14501, 1:150) antibodies were used. Sections were incubated with Brightvision poly-alkaline phosphatase (AP)-anti-
rabbit (Immunologic) for 30minutes at room temperature, and thenwashedwith PBS. AP activity was visualizedwith the AP substrate
kit III Vector Blue (SK-5300, Vector laboratories Inc.). To remove the first primary antibody, sectionswere incubated at 121C in citrate
buffer (10mMNaCi, pH 6,0) for 10min. Incubation with the second primary antibody was performed overnight at 4C. AP activity was
visualized with the alkaline phosphatase substrate kit I Vector Red (SK-5100, Vector laboratories Inc.). Negative control sections
incubated without the primary antibodies or with the primary antibodies, followed by heating treatment were essentially blank.
Immunohistochemistry on mouse tissue and cultured cells
Mouse brains were dissected from 8 to 12weeks oldmice intracardially perfusedwith phosphate-buffered saline (PBS) and 4%para-
formaldehyde (PFA) in PBS. After post-fixation (PFA, overnight) and cryopreservation in 30% sucrose/PBS, brains were cut in 50 mm
coronal sections using a sliding microtome. Free-floating sections were blocked in 1% horse serum in PBS and incubated with pri-
mary followed by secondary antibodies diluted in PBS, supplemented with 1% bovine serum albumin (BSA), 1% normal donkey
serum (NDS) and 0.5% Triton-X.
After PTZ kindling experiments, mouse brains were dissected and rapidly frozen. Next, 25 mm coronal sections were cut using a
cryostat, immediately mounted on glass slides, and kept at 20C until further use. Prior to staining, the sections were thawed at
room temperature for 30min and fixed in 4%PFA/PBS for 30min. Sectionswere blocked and incubatedwith antibodies as described
for free-floating sections above. For detection of 8OHdG, the blocking buffer contained 10% NDS, 1% BSA, and 0.3% Triton-X in
TBS-T (132 mM NaCl, 2.7 mM KCl, 25 mM Tris pH 7.5, 0.1% Tween-20) and antibodies were diluted in TBS-T.
TUNEL reaction was performed using a commercially available kit (Roche). Sections were thawed for 30 min at 4C and fixed in
25% acetic acid in ethanol for 30 min at 4C. Next, the sections were blocked with 2% BSA, 1.5% normal goat serum, 0.1%
Triton-X in PBS, and subjected to TUNEL reaction as described in the manufacturer’s manual.
To visualize glutathione, the sections were first incubated for 4 hours at 4C in 10mMN-ethylmaleimide (NEM)/PBS. After washing
with PBS, the sections were incubated overnight at 4C with anti-GSH:NEM antibody in PBS supplemented with 0.3% Trition-X.
Next, they were washed and incubated for 2 hours at room temperature with fluorescently labeled secondary antibody.
C6 cells grown on glass coverslips were fixed with 4% PFA/PBS. Cultured neurons grown on glass coverslips were fixed with 4%
PFA/PBS at DIV 10-12. Next, the cells were washed with PBS, blocked for 1 hour in PBS supplemented with 5% NDS and 0.3%
Triton-X, and incubated with primary antibodies diluted in PBS with 1% BSA and 0.3% Triton-X.
Following antibodies were used for immunostainings: anti-EAAT3 (Cell Signaling, #14501, 1:100; Santa Cruz Biotechnology,
SC7761, 1:100), anti-GAD67 (EMD Millipore, MAB5406, 1:100), anti-Rab5 (Cell Signaling, #2143, 1:100), anti-Rab7 (Cell Signaling,
#9367, 1:100), anti-Rab11 (Cell Signaling, #5589, 1:100), anti-SorCS2 (R&D Systems, AF4237, 1:100), anti-GSH:NEM (Millipore,
MAB3194, 1:100). Primary antibodies were visualized using Alexa Fluor 555, 488 or 647 secondary antibody conjugates. 8OHdGe4 Cell Reports 26, 2792–2804.e1–e6, March 5, 2019
was immunodetected using FITC-conjugated antibody (Santa Cruz Biotechnology, SC93871, 1:50) and GFAP was detected using
Cy-3 conjugated antibody (Sigma-Aldrich C9205, 1:1,500).
The cells and tissue sections were counterstained with DAPI and mounted with DAKO fluorescence mounting medium.
Tissue fractionation
Brain subcellular fractionations were performed as illustrated on Figure S4A. Brain tissues (hippocampi and cortices) from 8 to
12 weeks old mice were used. For each preparation, tissue from 2 mice was pooled. Tissue was homogenized with glass homog-
enizer in Tris-buffered sucrose with Ca and Mg (0.32 M sucrose, 6 mM Tris, 1 mMMgCl2, 0.5 mM CaCl2, protease and phosphatase
inhibitors, pH 8). The resulting suspension was centrifuged (1,400x g, 20 min) yielding the supernatant (S1a) and the pellet, that was
homogenized again in Tris-buffered sucrose with Ca and Mg and centrifuged to remove nuclear debris (710x g 10 min) and to collect
the supernatant (S1b). Supernatants S1a and S1b were combined to get a total lysate (S1) that was further centrifuged (13,800 3 g,
30 min) to pellet the crude membrane fraction (P2). The resulting supernatant (S2) was subjected to ultracentrifugation (100,0003 g,
1 h) to yield the intracellular vesicles fraction (P3). The P2 fraction was homogenized in Tris-buffered sucrose (0.32 M sucrose, 6 mM
Tris pH 8) and layered onto a discontinuous sucrose density gradient (0.85M, 1.0M, 1.2M sucrose buffered with 6mMTris pH 8) and
centrifuged (82,500x g, 2h) to recover the extrasynaptic membranes at the interphase between the layered P2 fraction and 0.85 M
sucrose, and the synaptosomal fraction at the interphase between 1.0 M and 1.2 M sucrose. The synaptosomal fraction was further
supplemented with Triton X-100 to a final concentration of 0.5%, and incubated on ice for 15 min. Further centrifugation (32,000x g,
20 min) pelleted the PSD1 fraction, that was resuspended in 40 mM Tris pH 8.
To obtain only P2 and P3 fractions, simplified protocol was used. Tissue (cortex and hippocampus, 1 hemi-brain per sample) was
homogenized with glass homogenizer in a sucrose buffer containing 0.32M sucrose,10mM Tris-HCl (pH 7.5), 1mM EDTA and pro-
tease and phosphatase inhibitors. Homogenate was centrifuged at 1,000x g for 10 min to remove the nuclear fraction and tissue
debris. Resulting supernatant (total lysate) was centrifuged at 10,000x g for 15 minutes to yield a crude membrane fraction (P2)
and S2. Further centrifugation (100,000x g, 1 h) of S2 fraction pelleted the intracellular vesicles fraction (P3). P2 fraction was resus-
pended in sucrose buffer with 0.5% Triton X-100 and P3 fraction was resuspended in 10 mM Tris buffer.
Protein concentrations were measured for all the fractions and equal amounts of protein were loaded on an SDS-PAGE gel for
western blot analysis.
Immunoprecipitations
Hippocampi from WT and S2KO mice were homogenized in lysis buffer containing 20 mM Tris pH 7.5, 150 mM NaCl, 1 mM CaCl2,
1 mMMgCl2, protease and phosphatase inhibitors, and kept on ice for 20 min. Next, the lysates were centrifuged (1,000x g, 10 min)
and the tissue debris was discarded. CHAPS was added to the lysates to a final concentration of 0.6% and the lysates were rotated
for 1 hour at 4C. After centrifugation (16,100x g, 15 min), the supernatant was loaded on protein G agarose beads coupled to anti-
SorCS2 antibody (R&D, AF4237) or to unspecific sheep IgG, rotated overnight and washed 3 times with lysis buffer supplemented
with 0.3% CHAPS. Proteins bound to the resin were released by boiling in Laemmli buffer and analyzed by western blot.
Chinese hamster ovary (CHO) cells were transfected with expression constructs encoding rat EAAT3 and GFP-tagged b-Galac-
tosidase or murine SorCS2 using LipofectamineTM 2000 reagent (Invitrogen). Two days after transfection, cells were washed twice
and scraped in TBS-Ca-Mg buffer, and centrifuged to obtain a cell pellet (16,100x g, 15 min). The cell pellet was resuspended in lysis
buffer (20 mM Tris pH 7.5, 150 mM NaCl, 1 mMMgCl2, 1 mM CaCl2) supplemented with 0.6% CHAPS, and protease and phospha-
tase inhibitors. After shaking for 30 minutes on ice, the lysate was centrifuged to remove the cell debris (16,100x g, 15 min). The
supernatant was applied to GFP Trap beads (Chromotek) for GFP immunoprecipitation. The samples were rotated for 1 hour at
4Cbefore the resin waswashed 3 timeswith lysis buffer supplementedwith 0.2%CHAPS. Proteins bound to the resin were released
by boiling in Laemmli buffer and analyzed by western blot.
Western blot
Tissue and cell lysates were analyzed by western blot using the following antibodies: anti-SorCS2 (R&D Systems, AF4237, 1:1000),
anti-EAAT3 (Cell Signaling, #14501, 1:1000), anti-p-ERK (Cell Signaling, #4370, 1:2000), anti-tubulin (EMD Millipore, CP06, 1:5000),
anti-mGlur2/3 (Novus Biologicals, NB300-124, 1:1000), anti-actin (Abcam, ab8227, 1:2000), anti-JWA (Trans Genic, KR057, 1:250),
anti-N-cadherin (Cell Signaling, #14215, 1:1000), anti-GFP (MBL International, MBL598, 1:2000), anti-Rab11 (Cell Signaling, #5589,
1:1000), anti-synaptophysin (Synaptic Systems, 101011, 1:5000), anti-GluA1 (EMD Millipore, MAB2263, 1:1000), anti-GluA2 (EMD
Millipore, MABN71, 1:1000), anti-PSD95 (Cell Signaling, #3409, 1:1000), anti-HO-1 (Cell Signaling, #70081, 1:1000). After incubation
with secondary antibodies coupled to HRP, chemiluminescent signal was registered with use of digital LI-COR imaging system.
Quantitative RT–PCR
Total RNA was extracted from tissue and cell lysates using TRIzol reagent and purified with RNeasy Mini Kit (QIAGEN). Reversely
transcribed cDNA from total RNA was subjected to qRT–PCR using the following Taqman Gene Expression Assays: Actb (actin,
Mm02619580), Ar6ip5 (JWA, Mm00480826), Grm3 (mGlur3, Mm00725298), EAAT3 (Mm00436590). Fold change in gene expression
was calculated using the cycle threshold (CT) comparative method (2ddCT) normalizing to Actb CT values.Cell Reports 26, 2792–2804.e1–e6, March 5, 2019 e5
Cysteine and glutamate uptake assays
Cultures of mixed cortical-hippocampal neurons from WT and S2KO mice were used at DIV 10-13.
Cells were washed 3 times with warm assay buffer (5 mM Tris pH 7.5, 10 mMHEPES, pH 7.27, 2.5 mMKCl, 1.2 mMCaCl2, 1.2 mM
MgCl2, 1.2 mM K2HPO4, 10 mM glucose; 140 mMNaCl) and then incubated with the warm assay buffer containing L-[35S]-cysteine
(0.005 uCi/ul, PerkinElmer), unlabeled L-cysteine (10 mM, Sigma-Aldrich) andDTT (100 mM, 1,4-Dithiothreitol, Sigma-Aldrich) or warm
assay buffer containing L-[3,4-3H]-glutamic acid (100 nM, PerkinElmer) and unlabeled L-glutamic acid (10 mM, Sigma-Aldrich). To
study Na-independent cysteine uptake, the sodium chloride in the assay buffer was replaced with choline chloride (Sigma-Aldrich,)
and the pH was adjusted with KOH.
Cysteine uptake assays were performed at room temperature for 10, 30, 60, and 360 s. Glutamate uptake was performed at 37C
for 0.5, 1, 6, and 15minutes. At indicated time points, cells were rapidly washed 3 times with cold Tris-Ca-Mg buffer followed by lysis.
Cells were scraped in lysis buffer (50 mM Tris, pH 7.4, 140 mMNaCl, 1% Triton X-100) supplemented with protease inhibitor cocktail
and incubated for 30minutes on ice. Subsequently, the lysates were centrifuged at 13,400x g for 10minutes and the supernatant was
used for further analysis.
The radioactive cysteine and glutamic acid contents were determined in a Liquid Scintillation Analyzer (Tri-Carb 2800TR, Perki-
nElmer) using 10 ml of the supernatant sample in 4 mL of liquid scintillation cocktail (Rotiszint eco plus, Carl Roth).
Valueswere normalized to protein content and, in case of cysteine uptake, the values obtained for Na-independent cysteine uptake
were subtracted from the total uptake. Finally, values were given relative to the value obtained for the earliest time point of the uptake
experiment (set to 100%).
QUANTIFICATION AND STATISTICAL ANALYSIS
Image quantification
Western blot signals were quantified using the Image Studio Lite software. For quantification of multiple bands (monomers and ag-
gregates), the bands intensities were quantified separately and next combined.
Microscopy images were quantified using Fiji software. Signal intensities were measured on single channel images as mean gray
value for a selected area. Colocalization analysis for neuronal images was performed with Colocalization Threshold plugin with
manual selection of the region of interest, covering neuronal cell soma and initial segments of primary dendrites. Single z-plane im-
ages were used for calculating Mander’s coefficient (tM1).
To quantify the number of TUNEL-positive cells, the CA2/3 region was manually selected, color channels were separated, and
threshold was applied tominimize the background signal. Next, DAPI-positive regions were used tomask the green channel (TUNEL)
and TUNEL-positive particles were counted automatically.
The 8OHdG signal intensity was quantified in manually selected CA and DG regions after separating the channels and applying a
threshold tominimize the background signal. For each set of tissue sections stained in parallel, intensities were normalized to amean
value obtained for the WT mice.
The GSH:NEM signal intensity was quantified along with DAPI signal intensity within a manually selected region containing CA2
neurons. The GSH:NEM signal measurement was further normalized to DAPI intensity in the same region.
Statistical analysis
For all in vivo experiments, an indicated number n is the number of mice per group used in an experiment. For neuronal culture ex-
periments, an indicated number n is the number of independent neuronal preparations (biological replicates) used for western blot or
qRT-PCR analysis. In case of colocalization studies, n is the number of individual cells quantified in a given experiment, and every
experiment was replicated at least three times on independent neuronal cultures.
Each mouse (or biological replicate/individual cell in neuronal cell culture experiments) represents a statistically independent
experimental unit, which was treated accordingly as an independent value in the statistical analyses. Statistical analyses were per-
formed using GraphPad Prism software. For comparison between two experimental groups, a two-tailed unpaired t-test was used.
PTZ kindling response was assayed with repeated-measures two-way ANOVA. Survival curve was analyzed using Gehan-Breslow-
Wilcoxon test. For all other data with two independent variables (factors), two-way ANOVA with Sidak’s multiple comparisons test
was applied. Where applicable, outlier analysis was performed using Grubb’s test. The details of statistical analysis are specified
in the figure legends.
In mass spectrometry experiments, differences in protein levels were compared by Welch t test with Benjamini-Hochberg correc-
tion of p-value, with an FDR of 0.15.e6 Cell Reports 26, 2792–2804.e1–e6, March 5, 2019
